⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 19, 2024Pharmacopsychiatry

Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression

Taro Kishi Kenji Sakuma Shun Hamanaka Yasufumi Nishii Nakao Iwata

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Lurasidone (LUR) was compared with quetiapine extended release (QUE-ER) regarding 1-year discontinuation in patients with bipolar depression (n=317).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kishi et al. (2024) studied this question.

synapsesocial.com/papers/68e64185b6db6435875d3352 https://doi.org/10.1055/a-2331-2300

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar DisorderRetrospective Study · 2018 · 9 citations
2Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial2024 · 2 citations
3Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medicationscohort · 2023 · 17 citations
4Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode2024 · 2 citations
5The efficacy and safety of lurasidone in adolescents with bipolar disorder: a up-to-date drug profileRandomized Controlled Trial · 2026
6Long-term safety and tolerability of lurasidone in schizophreniaRCT · 2012 · 122 citations
7Lurasidone in Schizophrenia Management: A Comprehensive 12-Week Post-Marketing Surveillance Study in Chinese PatientsOriginal Research · 2026
8Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation studyRCT · 2015 · 11 citations
9Aripiprazole-Induced Gambling Disorder as an Adverse Drug Reaction in Tourette Syndrome: A Case ReportPharmacopsychiatry · 2026
10Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in MicePharmacopsychiatry · 2026

More from Pharmacopsychiatry

More from Fujita Health University